Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-28 4:48 pm Sale | 2026-06-30 | 13G | PMV PHARMACEUTICALS INC PMVP | Sio Capital Management, LLC | 2,634,137 4.940% | -442,443 (-14.38%) | Filing History |
| 2026-07-10 11:40 am Sale | 2026-06-30 | 13G | PMV PHARMACEUTICALS INC PMVP | ArrowMark Colorado Holdings, LLC | 1,959,579 3.670% | -1,130,514 (-36.59%) | Filing History |
| 2026-05-15 4:05 pm Purchase | 2026-03-31 | 13G | PMV PHARMACEUTICALS INC PMVP | Euclidean Capital LLC | 2,627,643 4.900% | 290,734 (+12.44%) | Filing History |
| 2026-05-04 4:14 pm Purchase | 2026-03-31 | 13G | PMV PHARMACEUTICALS INC PMVP | Sio Capital Management, LLC | 3,076,580 5.770% | 440,032 (+16.69%) | Filing History |
| 2026-03-04 9:12 pm Sale | 2026-03-02 | 13D | PMV PHARMACEUTICALS INC PMVP | ORBIMED ADVISORS LLC | 0 0.000% | -4,975,291 (Position Closed) | Filing History |
| 2026-02-17 4:36 pm Sale | 2025-12-31 | 13G | PMV PHARMACEUTICALS INC PMVP | ArrowMark Colorado Holdings, LLC | 3,090,093 5.810% | -557,198 (-15.28%) | Filing History |
| 2026-02-09 2:19 pm Purchase | 2025-12-31 | 13G | PMV PHARMACEUTICALS INC PMVP | BML Investment Partners, L.P. | 5,292,000 9.900% | 1,825,316 (+52.65%) | Filing History |
| 2025-11-12 08:00 am Sale | 2025-09-30 | 13G | PMV PHARMACEUTICALS INC PMVP | Sio Capital Management, LLC | 2,636,548 4.980% | -1,098,848 (-29.42%) | Filing History |
| 2025-10-27 5:12 pm Sale | 2025-10-23 | 13D | PMV PHARMACEUTICALS INC PMVP | ORBIMED ADVISORS LLC | 4,975,291 9.400% | -1,587,786 (-24.19%) | Filing History |
| 2025-09-23 8:34 pm Purchase | 2025-09-16 | 13G | PMV PHARMACEUTICALS INC PMVP | TANG CAPITAL MANAGEMENT, LLC | 4,720,357 8.900% | 4,720,357 (New Position) | Filing History |
| 2025-08-14 4:02 pm Sale | 2025-06-30 | 13G | PMV PHARMACEUTICALS INC PMVP | PFM Health Sciences LP | 0 0.000% | -3,301,942 (Position Closed) | Filing History |
| 2025-08-13 2:00 pm Unchanged | 2025-06-30 | 13G | PMV PHARMACEUTICALS INC PMVP | Sio Capital Management, LLC | 3,735,396 7.190% | 0 (Unchanged) | Filing History |
| 2025-05-15 4:08 pm Purchase | 2025-03-31 | 13G | PMV PHARMACEUTICALS INC PMVP | PFM Health Sciences LP | 3,301,942 6.400% | 703,115 (+27.06%) | Filing History |
| 2025-04-08 3:14 pm Purchase | 2025-03-31 | 13G | PMV PHARMACEUTICALS INC PMVP | Sio Capital Management, LLC | 3,735,396 7.190% | 163,229 (+4.57%) | Filing History |
| 2025-02-21 4:02 pm Purchase | 2025-02-13 | 13G | PMV PHARMACEUTICALS INC PMVP | PFM Health Sciences LP | 2,598,827 5.000% | 2,598,827 (New Position) | Filing History |
| 2025-02-14 10:15 am Purchase | 2024-12-31 | 13G | PMV PHARMACEUTICALS INC PMVP | BML Investment Partners, L.P. | 3,466,684 6.700% | 196,777 (+6.02%) | Filing History |
| 2025-02-14 10:06 am Unchanged | 2024-12-31 | 13G | PMV PHARMACEUTICALS INC PMVP | BML Investment Partners, L.P. | 3,269,907 6.300% | 0 (Unchanged) | Filing History |
| 2025-02-10 12:58 pm Purchase | 2024-12-31 | 13G | PMV PHARMACEUTICALS INC PMVP | Sio Capital Management, LLC | 3,572,167 6.900% | 3,572,167 (New Position) | Filing History |
| 2024-12-12 12:29 pm Purchase | 2024-12-06 | 13G | PMV PHARMACEUTICALS INC PMVP | BML Investment Partners, L.P. | 3,269,907 6.300% | 3,269,907 (New Position) | Filing History |
| 2024-11-14 12:24 pm Purchase | 2024-09-30 | 13G | PMV PHARMACEUTICALS INC PMVP | ArrowMark Colorado Holdings, LLC | 3,647,291 7.080% | 933,148 (+34.38%) | Filing History |